Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial.

Long-term visit-to-visit HbA1c variability was a strong predictor of all-cause mortality. HbA1c VIM combined with HbA1c mean conferred an increased risk for all-cause mortality in the intensive-therapy group.